Odyssey Therapeutics, Inc.
NASDAQ:ODTXBiotechnology
-$0.01 today
- Market cap
- $912.33M
- Beta
- 0.00
Volume 0.37M
Average 0.43M
ODTX Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Deferred Revenue history
Currency unavailable · from the balance sheet
No Deferred Revenue data reported for this period type.
Deferred Revenue vs competitors
How ODTX compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.66M USD | -34.2% | +417.3% | 1.1% | |
ALMSAlumis Inc. Common Stock | Jun 2026 | $6.67M USD | — | — | 1.2% |
| Mar 2026 | $3.97M USD | — | — | 2.0% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €1.69M EUR | — | — | 1.0% |
| Sep 2026 | $0 USD | — | — | 0.0% | |
ORKAOruka Therapeutics, Inc. | Sep 2026 | $0 USD | — | — | 0.0% |
| Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding ODTX) | — | -67.1% | +417.3% | 0.5% | |
Competitors are the stored peer set for ODTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Odyssey Therapeutics, Inc.
NASDAQ:ODTX
Intrinsic Alpha fair value
Locked
Current Price
$18.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.